Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating

Clinical Trial Summary

The purpose of this study is to show if the adoptive cellular therapy with autologous dendritic cells and cytokine-induced killer cells (CIK) combined with concurrent chemoradiation could improve the quality of life of the patients with locally advanced esophageal cancer, compared with concurrent chemoradiation only.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05059444` - ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Not yet recruiting	`NCT05996484` - Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma	Phase 2
Recruiting	`NCT02355249` - Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer	Phase 3
Not yet recruiting	`NCT05937438` - Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma	Phase 1/Phase 2
Recruiting	`NCT05777707` - Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma	Phase 1/Phase 2
Recruiting	`NCT02527057` - Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer	N/A
Withdrawn	`NCT00636298` - Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy	Phase 2
Recruiting	`NCT06009705` - Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer
Recruiting	`NCT04652180` - Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .	N/A
Recruiting	`NCT04147494` - Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues	Early Phase 1
Withdrawn	`NCT03220009` - Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma	Phase 2
Recruiting	`NCT06199895` - Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer	Phase 2
Completed	`NCT00590031` - Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.	Phase 2
Active, not recruiting	`NCT00176800` - Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma	Phase 2
Completed	`NCT03099382` - Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer	Phase 3
Active, not recruiting	`NCT04607590` - Yoga Program for Improving the Quality of Life in Couples Coping With Cancer
Recruiting	`NCT00991094` - Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Completed	`NCT01855854` - Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH	Phase 2
Recruiting	`NCT06265285` - Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program	Phase 2
Recruiting	`NCT05795595` - A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors	Phase 1/Phase 2

NCT number	NCT01691625
Study type	Interventional
Source	Capital Medical University
Contact
Status	Completed
Phase	N/A
Start date	September 2012
Completion date	December 2021

Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms